Active	Status	Sponsor type	Region	Phase	Filter
6 Active 3 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yeh, Daniel Dante
CASA RELAX, NCT05002829: Restricted or Liberal Antibiotics After Appendectomy - Denver Health	Active, not recruiting	N/A	2275	US	Restricted Duration of SOC Antibiotic Use, Liberal Duration of SOC Antibiotic Use	Denver Health and Hospital Authority	Appendicitis	07/24	07/24
Jayaweera, Dushyantha T
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)	Completed	3	1403	US	Placebo, Montelukast	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	07/23	01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications	Active, not recruiting	3	15000	US	Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	06/24	11/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)	Active, not recruiting	3	15000	US	Placebo, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	06/24	11/24
NCT05869643: A Clinical Trial of STP0404 in Adults With HIV-1 Infection	Recruiting	2	36	US	Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir), Placebo	ST Pharm Co., Ltd.	HIV-1-infection	10/24	11/24
NCT06061081: A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1	Not yet recruiting	2	26	Europe, US, RoW	VH3739937, Placebo	ViiV Healthcare	HIV Infections	06/24	06/24
Kett, Daniel H
No trials found
Silverman, Richard B
No trials found
Jayaweera, Dushyanatha
No trials found